Crown Bioscience vs ONCOMATRYX
Crown Bioscience vs ONCOMATRYX, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crown Bioscience is on 54/100 and ONCOMATRYX on 50/100.
Where each one leads
Crown Bioscience
- our overall score: 54/100 against 50/100
- agent readiness: 48/100 against 36/100
- domain rating: 59/100 against 26/100
- funding raised: $262M against $107M
ONCOMATRYX
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Crown Bioscience | ONCOMATRYX |
|---|---|---|
| What it is | A global contract research organization specializing in preclinical and translational oncology research. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Drug Discovery, Biotech, Oncology, Contract Research Organization | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2006 | 2009 |
| Headquarters | San Diego, United States | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | Crown Bioscience | ONCOMATRYX |
|---|---|---|
| Employees | Not published | 36 |
| Total funding | $262M | $107M |
| Latest round | Acquisition | Funding Round |
| Valuation | $640M | Not published |
| LinkedIn followers | Not published | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crown Bioscience | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 50/100 |
| Traction | 40/100 | 56/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 18/100 | 37/100 |
| Quality | 68/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 59/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crown Bioscience | ONCOMATRYX |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager, Segment, Hotjar +1 more | Google Analytics 4 |
| Support stack | Drift | Not detected |
Crown Bioscience vs ONCOMATRYX: common questions
Which is better, Crown Bioscience or ONCOMATRYX?
On our 0-100 score Crown Bioscience rates higher (54/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Crown Bioscience and ONCOMATRYX compare on the numbers?
Crown Bioscience leads on our overall score (54/100 against 50/100), agent readiness (48/100 against 36/100), domain rating (59/100 against 26/100), funding raised ($262M against $107M).
Read the full Crown Bioscience review and pricing or the ONCOMATRYX review and pricing. You can also browse other Crown Bioscience alternatives we track.